2Bouvier-Alias M,Patel K,Dahari H,et al.Clinical utilityof total HCV core antigen quantification:a new indirectmarker of HCV replication. Hepatology . 2002
3Muerhoff AS,Jiaang L,Shah DO,et al.Detection ofHCV core antigen in human serum and plasma with anantomated chemiluminescent immunoassay. Trans-fusion . 2002
6Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
7Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
8Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
9Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
10Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
6Yang JF, Lin YY, Hsieh MH, et al. Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups [J]. Kaohsiung J Med Sci, 2011, 27 (7): 258-263.
7Muerhoff AS, Jiang L, Shah DO, et ol. Detection of HCV core antigen in human serum and plasma with an automated chemi luminescent immunoassay [ J ]. Transfusion, 2002, 42 (3) : 349- 356.
8Morota K, Fujinami R, Kinukawa H, et o1. A new sensitive and automated chemiluminescent mieroparticle immunoassay for quantitative determination of hepatitis C virus core antigen [J].J Virol Methods, 2009, 157 (1): 8-14.
9Vermehren J, Susser S, Berger A, et al. Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection [J ]. J Clin Virol, 2012, 55 ( 1 ) : 17-22.
10Saldanha J, Heath A, Aberham C, et ol. World Heahh Organi- zation collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays [J ]. Vox Sang, 2005, 88(3): 202-204.
